YC-1
- Product Name
- YC-1
- CAS No.
- 170632-47-0
- Chemical Name
- YC-1
- Synonyms
- YC-1;CS-2261;Nsc728165;LIFICIGUAT;Lificiguat(YC-1);YC-1(Lificiguat);YC 1 (pharMaceutical);Lificiguat, 10 mM in DMSO;YC-1, guanylyl cyclase activator;YC-1 - CAS 170632-47-0 - Calbiochem
- CBNumber
- CB2395371
- Molecular Formula
- C19H16N2O2
- Formula Weight
- 304.34
- MOL File
- 170632-47-0.mol
YC-1 Property
- Melting point:
- 110-112℃
- Boiling point:
- 522.2±50.0 °C(Predicted)
- Density
- 1.24±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- DMSO: 12 mg/mL
- pka
- 13.83±0.10(Predicted)
- form
- solid
- color
- white
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
Safety
- WGK Germany
- 3
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- Y102
- Product name
- YC-1
- Purity
- powder
- Packaging
- 5mg
- Price
- $192
- Updated
- 2025/07/31
- Product number
- 688100
- Product name
- YC-1
- Packaging
- 5mg
- Price
- $219
- Updated
- 2023/01/07
- Product number
- 81560
- Product name
- YC-1
- Purity
- ≥99%
- Packaging
- 1mg
- Price
- $18
- Updated
- 2024/03/01
- Product number
- 81560
- Product name
- YC-1
- Purity
- ≥99%
- Packaging
- 5mg
- Price
- $73
- Updated
- 2024/03/01
- Product number
- Y102
- Product name
- YC-1
- Purity
- powder
- Packaging
- 25mg
- Price
- $827
- Updated
- 2025/07/31
YC-1 Chemical Properties,Usage,Production
Description
YC-1 (170632-47-0) is a nitric oxide-independent activator of soluble guanylyl cyclase (sGC). Significantly elevates cGMP levels and inhibits collagen-stimulated aggregation of rabbit platelets (IC50?= 14.6 μM).1?Induces human endometrial cancer cell senescence via modulation of HIF1α activity.2?Induces degradation of HIF1α.3?Protects against glutamate-induced neuronal damage4?and β-amyloid-induced toxicity in differentiated PC12 cells5.
Uses
YC-1 has been used as a hypoxia-inducible factor 1α (HIF-1α) inhibitor:
- to reduce hypoxia induced Jagged1 expression in cardiomyocytes (CMs)
- to study its effect on progenitor expansion and CD34+ and side population (SP) cell phenotype and on the proliferation rate of cells with an ability to form long term colony forming units
- to study its effect on regulating sphingosine 1-phosphate (S1P) bound to albumin induced plasminogen activator inhibitor 1 (PAI-1) expression by activating Rho/ Rho-associated protein kinase (ROCK) pathway.
Definition
ChEBI: Lificiguat is a member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation. It has a role as an antineoplastic agent, a soluble guanylate cyclase activator, an apoptosis inducer, a platelet aggregation inhibitor and a vasodilator agent. It is a member of indazoles, a member of furans and an aromatic primary alcohol.
General Description
A nitric oxide-independent, superoxide-sensitive activator of soluble guanylyl cyclase. Inhibits platelet adhesion to collagen and acts as an antithrombotic agent. Reported to reduce HIF-1α levels and xenograft growth.
Biochem/physiol Actions
YC-1 activates soluble guanylyl cyclase and prevents platelet aggregation and vascular contraction. It has a potential to treat circulation disorders. YC-1 also has an ability to inhibit hypoxia-inducible factor 1α (HIF-1α) activity in vitro. It acts as a potential antiangiogenic anticancer agent.
storage
+4°C
References
[1] E. MARTIN F M Yu chen Lee. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components[J]. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98 1: 12938-12942. DOI:10.1073/pnas.231486198
[2] HIDENORI KATO. Induction of human endometrial cancer cell senescence through modulation of HIF-1α activity by EGLN1[J]. International Journal of Cancer, 2005, 118 5: 1144-1153. DOI:10.1002/ijc.21488
[3] HYE-LIM KIM. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.[J]. International journal of oncology, 2006, 29 1: 255-260.
[4] SHIH-HUANG TAI. Therapeutic window for YC‑1 following glutamate‑induced neuronal damage and transient focal cerebral ischemia.[J]. Molecular medicine reports, 2018: 6490-6496. DOI:10.3892/mmr.2018.8660
[5] YUNG-CHIEH TSAI. The role of heat shock protein 70 in the protective effect of YC-1 on β-amyloid-induced toxicity in differentiated PC12 cells.[J]. PLoS ONE, 2013: e69320. DOI:10.1371/journal.pone.0069320
YC-1 Preparation Products And Raw materials
Raw materials
Preparation Products
YC-1 Suppliers
- Tel
- 526763801 13301653310
- Fax
- +86-21-51619052
- 526763801@qq.com
- Country
- China
- ProdList
- 9274
- Advantage
- 55
- Tel
- Fax
- 86-21-57758967
- sales@boylechem.com
- Country
- China
- ProdList
- 2922
- Advantage
- 55
- Tel
- 400-6009262 16621234537
- Fax
- 021-64823266
- chenyj@titansci.com
- Country
- China
- ProdList
- 14101
- Advantage
- 59
- Tel
- 1-(800)-881-8210
- Fax
- 615-250-9817
- inquiries@lgmpharma.com
- Country
- United States
- ProdList
- 2123
- Advantage
- 70
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Country
- China
- ProdList
- 4747
- Advantage
- 58
- Tel
- 021-58950125
- Fax
- (86) 21-58955996
- info@chemexpress.com
- Country
- China
- ProdList
- 7552
- Advantage
- 61
- Tel
- 400-6206333 13167063860
- Fax
- 021-50323701
- anhua.mao@aladdin-e.com
- Country
- China
- ProdList
- 25003
- Advantage
- 65
- Tel
- 021-51320588
- Fax
- 0086-21-51320502
- tauto@tautobiotech.com
- Country
- China
- ProdList
- 3988
- Advantage
- 66
- Tel
- 025-846993838003-8003 18013301590
- Fax
- 025-84699383-8003
- njduly@126.com
- Country
- China
- ProdList
- 3249
- Advantage
- 55
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
- Country
- China
- ProdList
- 3506
- Advantage
- 58